Hepatitis C remission rates improve with the addition of danoprevir to the current treatment regimen. Read about the new research here:
New hepatitis C drug shows potential in ... - Hepatitis C Trust
New hepatitis C drug shows potential in phase II trials
Written by
Hep_C_News_team
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
Moderation team
sam_hepctrustPartner